Posts Tagged with:


HGP – EVZIO® (naloxone HCl injection, USP) Auto-Injector Now Available to Patients in Select States Without a Prescription Through Kaléo’s New Virtual Standing Order Pilot Program and to Government Agencies at a Direct Purchase Price

April 5, 2018 | Read more >

HGP – U.S. FDA Approves Kaléo’s AUVI-Q® (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children

November 20, 2017 | Read more >

HGP – U.S. FDA Grants Priority Review for an Epinephrine Auto-Injector in Development by Kaléo Specifically for Infants and Small Children

July 27, 2017 | Read more >

HGP – Kaléo Announces U.S. Availability and Pricing to Patients of Auvi-Q® (Epinephrine Injection, USP) Auto-Injector, For Life-Threatening Allergic Reactions

January 19, 2017 | Read more >

HGP – Kaléo Announces 2017 U.S. Return Of Auvi-Q® (Epinephrine Injection, Usp) Auto-Injector For Life-Threatening Allergic Reactions

October 26, 2016 | Read more >